Clinical trials
Withdrawn Phase 1/2 Neoplasm Metastasis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2008 | 1 |
| 2011 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 2 |
| 2021 | 4 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 15 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 2 |
| Dana-Farber Cancer Institute | 1 |
| Edwards Lifesciences | 1 |
| Emmanuel Antonarakis, MD | 1 |
| H. Lee Moffitt Cancer Center and Research Institute | 1 |
| Hadassah Medical Organization | 1 |
| Joshua M Hare | 1 |
| Masonic Cancer Center, University of Minnesota | 1 |
| Medical College of Wisconsin | 1 |
| Merck Sharp & Dohme LLC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasm Metastasis | 15 |
| Breast Neoplasms | 4 |
| Carcinoma, Non-Small-Cell Lung | 4 |
| Neoplasms | 3 |
| Pancreatic Neoplasms | 3 |
| Adenocarcinoma | 2 |
| Colorectal Neoplasms | 2 |
| Liver Neoplasms | 2 |
| Lung Neoplasms | 2 |
| Melanoma | 2 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.